(IBD)?
About GlycanTrigger project
GlycanTrigger is a project funded by the European Union within the Horizon Europe Research and Innovation Actions, bringing together 9 organisations from 6 different European countries and 1 non-European country (USA).
In GlycanTrigger, we will investigate when, why and how changes in gut glycome trigger health-to-chronic inflammation transition. The project started in January 2023 and will be developed for 6 years under the coordination of Instituto de Investigação e Inovação em Saúde (i3S) from the University of Porto, Portugal. The GlycanTrigger consortium includes representatives from medical universities and research centers, clinical centers, one biotechnology company, one consultancy company, and one European patients’ association.
Key Numbers
Budget
6.8 M€
Duration
72 months
9 partners
6 European countries
1 USA
Diseases
Crohn’s disease (CD)
Ulcerative Colitis (UC)
Highlights
News & Events
1st GlycanTrigger Patients Symposium
The GlycanTrigger project consortium is pleased to invite you to the 1st GlycanTrigger Patients Symposium: Discussing Inflammatory Bowel Disease Prediction and Prevention. Date: November 19th, 2024Time: 5.30 - 7.00 [...]
PhD Candidate Carolina Dantas successfully completes probation year at ICBAS
We are pleased to announce that Carolina Dantas, a talented researcher and PhD candidate within the GlycanTrigger project, has successfully completed her probation year at the Institute of Biomedical [...]